← Leaderboards
Elise M Weerts
Johns Hopkins University
$16,468,322
Attributed
$19,222,749
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,222,749 · 11
By mechanism
R01$14,072,223 · 5
T32$2,760,787 · 1
R21$2,389,739 · 5
Top collaborators
- Eric C Strain5 shared
- Dean Foster Wong4 shared
- Gary S Wand3 shared
- Justin Charles Strickland2 shared
- George Bigelow1 shared
- David Wolinsky1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert N Cole$2,029,196
- Kristine Glunde$12,806,818
- Nancy A. Ator$7,737,168
- David Wolinsky$568,814
- Shruti H Mehta$41,677,787
Others in their field
Top investigators on “Abstinence”
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$37,092,310
- Robert M. Grant · J. David Gladstone Institutes$36,697,634
- T John Winhusen · University Of Cincinnati$34,347,789
- Stephen T Higgins · University Of Vermont &St Agric College$34,051,568
- Kenneth Silverman · Johns Hopkins University$30,748,980
- Barbara J Mason · Scripps Research Institute, The$30,396,565
Research focus
AbstinenceProceduresPharmaceutical PreparationsAlcoholsDoseSelf AdministrationBehaviorAgonistResponseBehavioralRelapseAlcohol DependenceDrinkingAlcohol ConsumptionReceptorBenzodiazepinesChronicNaltrexoneAlcohol ReinforcementLinkAcamprosateAlcohol Seeking BehaviorCuesPre-Clinical
Grant awards (50)
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving$672,377
R01 · FY2025 · AA
Human Behavioral Pharmacology of Substance Abuse$670,632
T32 · FY2025 · DA
Human Behavioral Pharmacology of Substance Abuse$626,100
T32 · FY2024 · DA
Preclinical Assessment of Medications for Alcohol Abuse$673,982
R01 · FY2023 · AA · contact PI
Human Behavioral Pharmacology of Substance Abuse$255,079
T32 · FY2023 · DA
Preclinical Assessment of Medications for Alcohol Abuse$680,409
R01 · FY2022 · AA · contact PI
Human Behavioral Pharmacology of Substance Abuse$625,288
T32 · FY2022 · DA
Preclinical Assessment of Medications for Alcohol Abuse$688,277
R01 · FY2021 · AA · contact PI
Human Behavioral Pharmacology of Substance Abuse$583,688
T32 · FY2021 · DA
Preclinical Assessment of Medications for Alcohol Abuse$714,069
R01 · FY2020 · AA · contact PI
PET Imaging of alpha-7-nAChR in Tobacco Use Disorder$245,625
R21 · FY2020 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$749,787
R01 · FY2019 · AA · contact PI
PET Imaging of alpha-7-nAChR in Tobacco Use Disorder$204,688
R21 · FY2019 · DA · contact PI
Development of a preclinical cannabinoid vaping model$204,688
R21 · FY2019 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$444,471
R01 · FY2018 · AA · contact PI
Development of a preclinical cannabinoid vaping model$245,625
R21 · FY2018 · DA · contact PI
Cannabinoid PET Imaging in Women Cannabis Users$204,662
R21 · FY2018 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$469,018
R01 · FY2017 · AA · contact PI
Cannabinoid PET Imaging in Women Cannabis Users$245,188
R21 · FY2017 · DA · contact PI
Laboratory studies on oxytocin for treatment of alcohol dependence$132,030
R21 · FY2017 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$470,464
R01 · FY2016 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$99,792
R01 · FY2016 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$435,600
R01 · FY2015 · AA · contact PI
Laboratory studies on oxytocin for treatment of alcohol dependence$224,955
R21 · FY2015 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$506,788
R01 · FY2014 · AA · contact PI
Laboratory studies on oxytocin for treatment of alcohol dependence$191,736
R21 · FY2014 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$316,023
R01 · FY2011 · AA · contact PI
Alcohol Sensitivity and PET Derived Measures of Opioid Activity$676,422
R01 · FY2010 · AA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$366,710
R01 · FY2010 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$328,779
R01 · FY2010 · AA · contact PI
Alcohol Sensitivity and PET Derived Measures of Opioid Activity$706,990
R01 · FY2009 · AA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$360,102
R01 · FY2009 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$332,100
R01 · FY2009 · AA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$374,596
R01 · FY2008 · DA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$365,349
R01 · FY2008 · AA · contact PI
Preclinical Assessment of Medications for Alcohol Abuse$381,349
R01 · FY2007 · AA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$354,138
R01 · FY2007 · DA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$17,200
R01 · FY2007 · DA · contact PI
Behavioral Pharmacology and GHB Physical Dependence$357,320
R01 · FY2006 · DA · contact PI
Studies on the role of GABA in Cocaine Addiction$282,515
R01 · FY2005 · DA
Studies on the role of GABA in Cocaine Addiction$292,026
R01 · FY2004 · DA
Dependence Potential of GHB, GBL and 1,4-BD$327,000
R01 · FY2003 · DA
Studies on the role of GABA in Cocaine Addiction$284,380
R01 · FY2003 · DA
Cue-Reactivity and Alcohol Self-Dosing$163,500
R21 · FY2003 · AA
Dependence Potential of GHB, GBL and 1,4-BD$327,000
R01 · FY2002 · DA
Studies on the role of GABA in Cocaine Addiction$276,926
R01 · FY2002 · DA
Cue-Reactivity and Alcohol Self-Dosing$163,500
R21 · FY2002 · AA
Studies on the role of GABA in Cocaine Addiction$413,264
R01 · FY2001 · DA
Dependence Potential of GHB, GBL and 1,4-BD$327,000
R01 · FY2001 · DA
Cue-Reactivity and Alcohol Self-Dosing$163,542
R21 · FY2001 · AA